Metropolis Healthcare’s Q2 profits skyrocket 31% – is this the start of unstoppable growth?
Metropolis Healthcare Limited, one of India’s prominent diagnostic chains, has reported a significant year-on-year profit growth of 31.0% in Q2 FY2024-25. This sharp increase is ... Read More
How Metropolis Healthcare achieved a stunning revenue growth in Q1 FY25
Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), a leading diagnostic chain in India, has announced a significant financial milestone with a 13.1% year-on-year increase ... Read More